FIELD: chemistry.
SUBSTANCE: invention relates to compounds of the formula
.
EFFECT: technical result: new compounds have been obtained, which are the SYK inhibitors and are useful for the treatment of autoimmune and inflammatory diseases.
9 cl, 2 tbl, 38 ex
| Title | Year | Author | Number |
|---|---|---|---|
| JAK INHIBITORS | 2010 |
|
RU2538204C2 |
| COMPOUNDS OF PYRIDAZINAMIDE AND THEIR USE AS SYNTHETIC SYNECKINASIS INHIBITORS (SYK) | 2013 |
|
RU2627661C2 |
| PHARMACEUTICAL COMPOUNDS | 2019 |
|
RU2821941C2 |
| DERIVATIVE 6-CARBONITRILE DIPYRIDOPYRROLES AND APPLICATION THEREOF IN CANCER TREATMENT | 2010 |
|
RU2575635C2 |
| SUBSTITUTED PYRROLES ACTIVE AS KINASES INHIBITORS | 2013 |
|
RU2666538C2 |
| IMIDAZOPYRIDAZINES | 2012 |
|
RU2662443C2 |
| JAK INHIBITOR COMPOUND AND USE THEREOF | 2020 |
|
RU2820445C2 |
| PYRROLOPYRAZINE KINASE INHIBITORS | 2012 |
|
RU2673064C2 |
| DISCLOSED ARE 6,7-DIHYDRO-5H-PYRIDO[2,3-C]PYRIDAZINE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF BCLXL PROTEINS AND PROAPOPTOTIC AGENTS FOR TREATING MALIGNANT NEOPLASMS | 2020 |
|
RU2832191C2 |
| POLYCYCLIC COMPOUNDS AND METHODS FOR TARGETED DEGRADATION OF POLYPEPTIDES OF FAST ACCELERATED FIBROSARCOMA | 2019 |
|
RU2830173C2 |
Authors
Dates
2018-06-07—Published
2013-08-19—Filed